These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16390880)

  • 21. Serotonin and molecular neuroimaging in humans using PET.
    Saulin A; Savli M; Lanzenberger R
    Amino Acids; 2012 Jun; 42(6):2039-57. PubMed ID: 21947614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression.
    Szapacs ME; Mathews TA; Tessarollo L; Ernest Lyons W; Mamounas LA; Andrews AM
    J Neurosci Methods; 2004 Dec; 140(1-2):81-92. PubMed ID: 15589338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tryptophan as an evolutionarily conserved signal to brain serotonin: molecular evidence and psychiatric implications.
    Russo S; Kema IP; Bosker F; Haavik J; Korf J
    World J Biol Psychiatry; 2009; 10(4):258-68. PubMed ID: 19921967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.
    Xie T; Tong L; McLane MW; Hatzidimitriou G; Yuan J; McCann U; Ricaurte G
    Neuropsychopharmacology; 2006 Dec; 31(12):2639-51. PubMed ID: 16452989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin: a common neurobiologic substrate in anxiety and depression.
    Eison MS
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):26S-30S. PubMed ID: 2198299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells.
    Launay JM; Schneider B; Loric S; Da Prada M; Kellermann O
    FASEB J; 2006 Sep; 20(11):1843-54. PubMed ID: 16940156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integration of neurobiology and psychopathology in a unified model of suicidal behavior.
    Mann JJ; Arango V
    J Clin Psychopharmacol; 1992 Apr; 12(2 Suppl):2S-7S. PubMed ID: 1374433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is there action beyond receptors?
    Hrdina PD
    J Psychiatry Neurosci; 1993 Mar; 18(2):57-9. PubMed ID: 8384874
    [No Abstract]   [Full Text] [Related]  

  • 29. [Behavior of 5-HT receptors during long-term antidepressant treatment and at discontinuation].
    Fillion G
    Encephale; 1995 Feb; 21 Spec No 1():3-6. PubMed ID: 7729352
    [No Abstract]   [Full Text] [Related]  

  • 30. Serotonin: la chica de moda in biological psychiatry?
    Banki CM
    Biol Psychiatry; 1991 May; 29(10):949-52. PubMed ID: 2065139
    [No Abstract]   [Full Text] [Related]  

  • 31. Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease.
    Pang TY; Du X; Zajac MS; Howard ML; Hannan AJ
    Hum Mol Genet; 2009 Feb; 18(4):753-66. PubMed ID: 19008301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior.
    Mann JJ
    Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):99S-105S. PubMed ID: 10432495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders.
    Blier P; de Montigny C
    Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):91S-98S. PubMed ID: 10432494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain 5-HT synthesis in the Flinders Sensitive Line rat model of depression: an autoradiographic study.
    Hasegawa S; Nishi K; Watanabe A; Overstreet DH; Diksic M
    Neurochem Int; 2006 Apr; 48(5):358-66. PubMed ID: 16427159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo assessment of aging changes in serotonin function.
    Meltzer CC; Reynolds CF
    Neuropsychopharmacology; 1999 Aug; 21(2):323-4. PubMed ID: 10432481
    [No Abstract]   [Full Text] [Related]  

  • 36. Pulmonary hypertension and the serotonin hypothesis: where are we now?
    MacLean MR
    Int J Clin Pract Suppl; 2007 Sep; (156):27-31. PubMed ID: 17663674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonergic neurotransmission in early Parkinson's disease: a pilot study to assess implications for depression in this disorder.
    Beucke JC; Uhl I; Plotkin M; Winter C; Assion HJ; Endrass T; Amthauer H; Kupsch A; Juckel G
    World J Biol Psychiatry; 2010 Sep; 11(6):781-7. PubMed ID: 20586535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receptor alterations associated with serotonergic agents: an autoradiographic analysis.
    Wamsley JK; Byerley WF; McCabe RT; McConnell EJ; Dawson TM; Grosser BI
    J Clin Psychiatry; 1987 Mar; 48 Suppl():19-25. PubMed ID: 3029045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypersensitive serotonergic receptors: a new hypothesis for one subgroup of unipolar depression derived from an animal model.
    Aprison MH; Hingtgen JN
    Adv Exp Med Biol; 1981; 133():627-56. PubMed ID: 6976074
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurochemical mechanisms of action of ECS: evidence from in vivo studies.
    Newman ME; Gur E; Shapira B; Lerer B
    J ECT; 1998 Sep; 14(3):153-71. PubMed ID: 9773355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.